Vext Science, Inc.

Equities

VEXT

CA9255401064

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange 20:05:45 12/06/2024 BST 5-day change 1st Jan Change
0.25 CAD 0.00% Intraday chart for Vext Science, Inc. +8.70% -13.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Vext Science, Inc., Q1 2024 Earnings Call, May 29, 2024
Vext Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (VEXTF) VEXT SCIENCE Reports Q1 Revenue $8.4M MT
Transcript : Vext Science, Inc., Q4 2023 Earnings Call, May 10, 2024
Vext Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (VEXTF) VEXT SCIENCE Reports Q4 Revenue $8.4M MT
Vext Announces Delay of Annual Filings and Postponement of Conference Call CI
Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive Role CI
Vext Science, Inc. Announces Board Changes CI
Transcript : Vext Science, Inc., Q3 2023 Earnings Call, Nov 28, 2023
Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (VEXTF) VEXT SCIENCE Reports Q3 Revenue $8.1M MT
Elevate Cannabis Co. completed the acquisition of Cultivation facility located in Prescott Valley, Arizona of Vext Science, Inc.. CI
Elevate Cannabis Co. entered into an agreement to acquire Cultivation facility located in Prescott Valley, Arizona of Vext Science, Inc. for $6.5 million. CI
Vext Science, Inc. announced that it has received $10 million in funding from LLF Financial S.A. CI
Vext Science Agrees to Buy 2 Additional Ohio Retail Locations; Plans Concurrent Private Placement; Down 13% MT
Vext Science, Inc. signed a letter of intent to acquire two cannabis dispensaries in Ohio from Big Perm?s DispensaryOhio, LLC for approximately $9.8 million. CI
Vext Science, Inc. announced that it expects to receive CAD 10 million in funding CI
Transcript : Vext Science, Inc., Q2 2023 Earnings Call, Aug 23, 2023
Vext Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Vext Science, Inc. Announces CFO Changes CI
Vext Science, Inc. Resigns Stephan Bankosz as Corporate Secretary, Effective August 25, 2023 CI
Transcript : Vext Science, Inc., Q1 2023 Earnings Call, May 25, 2023
Vext Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Vext Science, Inc., Q4 2022 Earnings Call, Mar 22, 2023
Chart Vext Science, Inc.
More charts
Vext Science, Inc. is a cannabis operator. The Company’s expertise spans from cultivation through to retail operations in markets of Arizona and Ohio. It manufactures THC cartridges, concentrates, edibles and accessories under the Vapen brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD and Herbal Wellness brands. It has THC concentrates, edibles, and distillate cartridge brands sold in various states dispensaries. It owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. Additionally, it provides management, advisory, cultivation, and dispensary services to entities in the cannabis field through joint operations agreements. It also sells CBD products and branded merchandise. Vapen Brands product is the wholesale product and sold in its dispensaries. Vapen Brand is an edible and concentrate brand. The Company also owns cannabis dispensary in Columbus, Ohio.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.25 CAD
Average target price
0.6333 CAD
Spread / Average Target
+153.33%
Consensus
  1. Stock Market
  2. Equities
  3. VEXT Stock
  4. News Vext Science, Inc.
  5. Earnings Flash (VEXTF) VEXT SCIENCE Reports Q3 Revenue $8.1M
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW